[1]
Adediran, E.O. 2022. Pefloxacin and its derivative, novel inhibitors of the SARS-CoV-2 Main protease (3CLpro) and their pharmacokinetics prediction: An in silico analysis. Archives of Pharmacy and Pharmaceutical Sciences. 6, 1 (Jun. 2022), 013–018. DOI:https://doi.org/10.29328/journal.apps.1001030.